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Abstract
Background: For a long time, chordoma has been known as an osseous tumor mainly found at the clivus and
sacrococcygeal region. However, spine extra-osseous chordoma (SEC) with a better prognosis than the classic type
has been neglected. According to our literature review, only several case reports have been published in English
literatures. Here in this article, three cases of SEC, plus a literature review, are presented.
Case presentation: Three cases of SEC were presented from our center. Surprisingly, neurologic tumors were
considered as the first diagnosis. Thereafter, en bloc resection was performed in all the three cases. Especially, the
dumbbell-shaped one in the cervical spine was removed by en bloc through the combined anterior and posterior
approach for the first time. Follow-up within 12–58 months after surgeries proved no recurrence or metastasis.
Conclusions: Spine extra-osseous chordoma, commonly located in the cervical and epidural region, is extremely
rarely met. SEC is characterized with less aggressiveness, the lower rate of recurrence and metastasis, and better
prognosis than those of the osseous origin. Though complete excision can be achieved generally, differential
diagnosis of spine neurogenic tumors and the following en bloc resection should be made as carefully as possible.
Keywords: Spine extra-osseous chordoma, Neurogenic tumor, Differential diagnosis, Prognosis
Abbreviations: CEA, Carcinoembryonic antigen; CK, Cytokeratin; CT, Computed tomography; EMA, Epithelial
membrane antigen; LRFS, Local relapse-free survival; MRI, Magnetic resonance imaging; OS, Overall survival;
PDGFR, Platelet-derived growth factor receptor; SEC, Spine extra-osseous chordoma
Background
Chordoma is a type of relatively rare tumor with an inci-
dence of about 0.8 per million [1], characterized with
bony involvement, strong local invasion, and high recur-
rence rate. According to the statistics, about 50 % of
spine chordomas are found in the sacrococcygeal region,
35–40 % at the clivus, and the rest 10–15 % in the mo-
bile spine (mainly in the cervical region) [2, 3]. Due to
its strongly local aggressiveness, chordoma usually
comes with a high recurrence rate and a poor prognosis.
Carpentier et al. [4] thought that the most significant
factor affecting prognosis is the first excision (partial,
total, or en bloc resection). Tong et al. [5] found that
total spondylectomy was an independent prognostic fac-
tor for both local relapse-free survival (LRFS) and overall
survival (OS). In the face of this tumor, surgeons are try-
ing their best to accomplish total en bloc spondylectomy
even at the cost of neurological function loss. Neverthe-
less, on account of the specialty and complexity of spine
anatomies, as well as the aggressiveness of chordoma,
the reported recurrence rate of chordoma is still as high
as 17 to 35 %. With the possibility of metastasis, poor
prognosis is natural.
Rarely, some chordomas of the spine present no bone
involvement, a condition that we call spine extra-
osseous chordoma (SEC). SEC, for a long time, has been
neglected because of its rather low incidence. Referring
to the literatures published in English, 17 cases [6–21] of
* Correspondence: songdw@sh163.net; jianruxiao83@163.com
†Equal contributors
Department of Bone Tumor Surgery, Changzheng Hospital, Second Military
Medical University, 415 Fengyang Road, Shanghai, China
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Yang et al. World Journal of Surgical Oncology  (2016) 14:206 
DOI 10.1186/s12957-016-0951-0
SEC reported before were classified into two groups: epi-
dural (intraspinal or intraspinal-extraspinal) and intra-
dural. For its rarity and similarity to neurogenic tumors,
the majority of these cases might be misdiagnosed as
neurinoma before operation. Fortunately, SECs have
shown a more favorable prognosis when the en bloc re-
section was performed. However, if treated as neuro-
genic tumors, especially for those dumbbell-shaped
tumors not wholly resected, the result may be a tragedy.
Here, we report three cases of SEC from our center, one
of which is the first dumbbell-shaped chordoma resected
in en bloc way with a combined posterior-anterior ap-
proach up to now, and a systematic review of SEC was
performed.
Case presentation
From 1991 to 2014, 251 spine chordoma surgeries were
conducted in our spine tumor center, only three cases
being SEC (Table 1). The first case was about a 50-year-
old woman with numbness in her right upper limb for
8 years. The cervical MR and CT revealed an intraspinal
mass without bone involvement that was soon consid-
ered as a neurinoma radiographically. The second pa-
tient complained of numbness and pain in the right
upper limb and weakness of the lower limbs. A
dumbbell-shaped mass with little secondary bone de-
struction was observed by both MR and CT. The last
one came with repetitionary sacrococcygeal discomfort
for 17 years and exacerbation for 1 month. With sacrum
MR and CT, the dumbbell-shaped neurogenic tumor
was suspected. For all of them, chordoma was not the
first diagnosis that came into our consideration.
All these three patients were treated with surgery of
total resection. Pathologically, chordoma was diagnosed
in three cases, and all of them recovered completely with
no recurrence and distant metastasis within a follow-up
ranging from 12 to 58 months. The total en bloc resec-
tion ensured the satisfied prognosis.
Case illustration
A 67-year-old man visited our center in 2014, complain-
ing of a 3-month discomfort in the right shoulder,
followed by numbness and pain in the right upper ex-
tremity and weakness in the lower extremities. Through
physical examination, his motor strength of the lower
limbs was 4/5, and both the Hoffmann and Babinski re-
flexes were negative. The cervical magnetic resonance
imaging (MRI) demonstrated that a giant dumbbell-
shaped mass was located in the right intervertebral for-
amen of C4 and C5, expanding from C4 to C5 vertebra,
Table 1 Summary of SECs reported in the literatures
Case Sex/age Systems Location MRI Resection Capsule A/T F/R
1 [8] M, 69 Pain of left hand and fingers C (IE) T1 hyper TR ND ND ND
2 [7] M, 38 Neck and shoulder pain C (IE) T2 hyper TR + − 84/−
3 [7] F, 44 Neck and arm pain C (IE) T1 hypo TR + − 12/−
4a F, 50 Right upper limb numbness C (ID) T1 iso, T2 hyper, enhancement TR + − 12/−
5 [21] F, 50 Neck pain, right arm numbness C (ID) Enhancement Subtot − ND ND
6 [6] F, 29 Neuralgia, dysesthesia C (IE) T1 hypo, T2 hyper TR + − 18/−
7 [12] M, 53 Right lower limb weakness, spine paresthesias C (ED) T1 hypo, T2 hyper TR + Radio 60/−
8 [16] M, 5 Neck weakness, stiffness C (IE) T1 iso, T2 hyper, enhancement TR + ND ND
9a F, 67 Right upper limb pain, lower limbs weakness C (IE) Enhancement TR + − 13/−
10 [11] F, 37 Paresthesia of arms C (ID) Enhancement PR + − 18/−
11 [18] M, 65 Gait disturbance C (ID) T1 iso, enhancement PR + − 18/−
12 [14] M, 36 Paraparesis, constipation urinary retention C (ID) T-L(IM) T2 hyper, enhancement partial ND Radio 0.75/−
13 [9] F, 33 Shoulders pain, gait disturbance T (ID) ND TR ND ND 12/−
14 [10] F, 31 Gait disturbance T (IE) T1 iso, T2 hypo, enhancement Partial ND Radio 36/−
15 [15] M, 6 Dorso-lumbar rigidity, buttock pain, L (IE) T1/2 iso, no enhancement ND + − −/−
16 [13] F, 17 Lower limbs pain L (ED) Enhancement TR + − 48/−
17 [19] F, 28 Low-back, lower limbs pain L-S (ID) T1 hyper, T2 iso TR + − 5/−
18 [20] F, 38 Bilateral buttock pain S (ID) T1 iso, T2 hyper TR + ND 6/−
19 [17] F, 50 Back pain, headache, right leg numbness C-S (ID/IM) ND subtot + − 19/−
20a F, 36 Sacrococcygeal region discomfort S (IE) Clear margin, enhancement TR + − 58/−
A/T adjuvant therapy, F/R follow up (month)/recurrence, hypo hypointense, hyper hyperintense, iso isointense, R resection, TR total resection, PR piecemeal
resection, ND not described, W week, Radio radiotherapy, ID intradural, ED epidural, IE intraspinal-extraspinal, IM intramedullary
aCases presented by our center
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with rare involvement of the bone. Inevitably, the spinal
cord was compressed. Moreover, hypointense signals on
T1 and hyperintense signals on T2 were witnessed
(Fig. 1a, b), as well as the heterogeneous enhancement
after injection of gadolinium (Fig. 1c). To evaluate the
function of vertebral arteries and corresponding risks
during the operation, both vertebral artery computed
tomography angiography (CTA) and preoperative occlu-
sion test of the right vertebral artery (VA) were per-
formed in our center, revealing the compressed right
vertebra artery (Fig. 1d) and the need to rid it. Either
MRI or CTA displayed a dumbbell-shaped tumor. A
neurogenic tumor was taken into account when he
attended the local hospital, of which we doubted to
some extent.
To make the preliminary diagnosis of this special mass
and a better treatment plan, we first carried out the nee-
dle biopsy. The pathological result surprised us that a
chordoma existed. In the light of this condition, it was
extraordinary for a dumbbell-shaped mass to be diag-
nosed as chordoma. We believe that it may represent an
uncommon morphology of chordoma: spine extra-
osseous chordoma (SEC).
Operation technique
Justified with these preoperative experiences, a
posterior-anterior approach was projected for the total
en bloc resection of this tumor. Eight lateral mass screws
were placed in the lateral masses of C2–3 and C6–7,
followed by the left rod fixation and the osteotomy of
spinous processes at C4–5. Subsequently, the intraspinal
(epidural) capsuled part was dissected from the com-
pressed dura matter but without removal. The involved
right fifth nerve root was ligated. The posterior approach
was done after fixation and suture.
Then, the patient was placed in the supine position for
the anterior approach. When exposing the surface of
C3–6 vertebras, a big capsulated mass came into sight.
The right vertebral artery was embraced. Taking the ag-
gressiveness and high recurrence rates of chordoma into
consideration, ligation of the right VA was performed.
After that, with a sagittal excision of C4–5 vertebras,
total resection of the tumor was finished successfully,
with an appropriate titanium mesh filled with allogeneic
bone and a suitable titanium plate placed at C3 and C6
vertebra. The dumbbell-shaped tumor was totally
resected without intraoperative complications.
Pathology
Normally, the resected mass was well-capsulated. Micro-
scopically, the mass was composed of lobules full of vac-
uolated physaliphorous cells rich in intra-cytoplasmic
mucin. There was no evidence of mitotic activity. The
immunohistochemical result was positive for the
Fig. 1 The preoperative and postoperative images. a, b A dumbbell-shaped and capsuled tumor was showed on T1 and T2, respectively. c Slight
enhancement after injection of gadolinium. d Very little secondary involvement of the bone. e, f, g Postoperative X-ray, MRI, and CT
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existence of S-100, epithelial membrane antigen (EMA),
CK (pan), and vimentin. The Ki-67 index was about 5 %
(Fig. 2a–e). According to the histological and immuno-
logical features, chordoma was diagnosed, conforming to
that got by the needle biopsy pathology.
Follow-up
The patient was able to walk around with the help of a
collar 3 weeks after the operation. His discomfort, numb-
ness, pain, and weakness of the lower extremities dwin-
dled soon after the operation, without any perioperative
complication. To examine the surgical efficiency, we ad-
vised him to take radiotherapy. The cervical CT and MRI
at 12 months after the surgery demonstrated no recur-
rence of the tumor and the perfect fusion of the bone graft
(Fig. 1e–g). Further follow-up continues.
Systematic review
We carried out the literature research by retrieving the
keywords like intradural, intraspinal-extraspinal, intrasp-
inal, extra-osseous, and dumbbell-shaped chordoma.
What is more, the abstracts were scanned by two au-
thors to choose the suitable articles, and then they read
the contents and the references carefully for other pos-
sible reports. Sixteen articles containing 17 SEC cases
(Table 1) were found. Surprisingly, the occurrence rate
of SEC in all chordoma victims was not reported. Thus,
we calculated the data in our single center. Two hun-
dred fifty-one spine chordoma surgeries were conducted
from 1991 to 2014, and only three cases were about
SEC. Then, the occurrence rate of SEC in all chordoma
victims was calculated to be 1.195 % (3/251). It is the
only occurrence rate of SEC up to now.
As presented in Table 1, there were 11 females and 9
males presenting no significant difference in sex. The
average age was 39.1 (ranging from 5 to 69) years old.
The clinical symptoms, mainly due to the compression
of nerve root and spinal cord, varied from each other.
Tumors were mainly located in the cervical region
(55 %) and epidural region (intraspinal or intraspinal-
extraspinal, 55 %). All cases except two (case 12, 19)
occurred as single lesion. In treating these 18 patients,
14 received complete total resection, and 4 received
subtotal resection through posterior or post-lateral ap-
proach. In terms of adjuvant therapy, only 3 of them
received radiotherapy for the incomplete resection. The
recorded postoperative follow-up lasted for 3 weeks to
84 months, and only one (case 12) died of respiratory
embarrassment, diaphragmatic paralysis, and quadripar-
esis caused by cervical compression 3 weeks after
thoracic operation. Recurrence or metastasis occurred in
just one of them (case 19) due to the subtotal or partial
removal.
Microscopically, they presented the classic features of
chordomas such as vacuolated physaliphorous cells
embedded in lakes of extracellular mucin. Notably, the
status of mitotic activity in five patients was respectively
described as: 5 %, minimal, low, scanty, and no. This
reminds us that SEC may be characterized with lower
aggressive behavior. Immunohistochemically, positive
immunoreactions were observed for the appearance of
cytokeratin, epithelial membrane antigen (EMA), vimen-
tin, and S-100. With antibodies against carcinoembryo-
nic antigen (CEA), aktin, and desmin, negative reactions
were observed. Ki67, a proliferation index, was recorded
only in two cases (about 1 %).
Discussion
Chordoma, comprising 1 to 4 % of all primary bone ma-
lignancy, is a type of locally aggressive tumor
Fig. 2 Immunohistochemical reactions. a CK pan (+). b EMA (+). c Vimentin (+). d S-100 (+). e: Ki67 (5 %); f HE staining
Yang et al. World Journal of Surgical Oncology  (2016) 14:206 Page 4 of 6
predominantly involving the sacrococcygeal and the cli-
val region. Only 10–15 % of the chordomas are located
in the mobile spine, in particular, the cervical region.
Histologically, chordomas are classified into conven-
tional, chondroid, and dedifferentiated variants. The
chordoma is well-known for its slow-growing but strong
local aggressiveness and high recurrence rate. At
present, therapeutic options mainly include surgery,
radiotherapy, and targeted therapy. Chemotherapy was
seldom used. Surgery, especially the total en bloc spon-
dylectomy, is thought to be the most preferred treatment
for chordoma even at the cost of neurological function
[4, 5]. However, the surgery is not able to ensure the ab-
solute survival. Given the anatomical complexity of the
spine, it is a big challenge for surgeons to resect the
tumor totally. What is more, the poor response to trad-
itional radiotherapy, especially chemotherapy, also brings
down the treatment’s effect. Due to its aggressiveness,
recurrence, and the opportunity of metastasis, chordoma
often has a terrible prognosis with the 5- and 10-year
overall survival (OS) rate of 65–78.6 % and 30–39.9 %,
respectively [1, 9, 22–24].
Chordoma is characterized with bone involvement. Yet,
the 20 SEC cases showed intradural or epidural (intrasp-
inal-extraspinal) or minimal secondary bone involvement.
As was illustrated by MR, 8 of the 20 cases presented
hypointense to isointense signals on T1-weighted image,
and 6 showed hyperintense signals on T2-weighted image.
Furthermore, 9 of them showed enhancement after the in-
jection of gadolinium. These features were similar to those
of neurinoma. Before the operation, 6 cases were first mis-
diagnosed with neurinoma. Others misdiagnosis included
arachnoid cyst, meningioma, and myxopapillary ependy-
moma. Therefore, for their special locations (intradural or
intraspinal-extraspinal), shapes and similar MR mani-
festations, the radiographic differential diagnosis be-
tween SECs and neurogenic tumors becomes quite
difficult. Despite this, differential diagnosis between
them must be taken into consideration in the face of
possible neurogenic tumors.
Histologically, the main body of classic chordomas con-
tains normal physaliphorous cells and lobulated struc-
tures. In the cases collected in our study, most of the
histological and immunohistochemical features were con-
sistent with those of the classic chordoma. Positive immu-
noreaction was strong for the appearance of cytokeratin,
epithelial membrane antigen (EMA), vimentin, and S-100.
Other positive immunohistochemical findings included
the platelet-derived growth factor receptor (PDGFR) α
and β, Ki67. Yet, antibodies against CEA, aktin, and des-
min did not show up. Few studies [25–27] reported that
MIB-1, an antibody reactive to Ki67 protein, ranged from
0 to 16.2 %, and was statistically associated with chordo-
ma’s local recurrence. For the present SECs, Ki67 was
recorded only in two cases, with a relatively low level of
1 %. Similarly, the mitotic activity of the several reported
cases was significantly low. These indicated that SEC may
have a less aggressive biological behavior. Brachyury, a
newly found biomarker in chordoma, has been widely
studied and used to diagnose chordoma [28, 29]. Though
seldom used in the present cases, it can be employed more
frequently for the diagnosis and differential diagnosis of
SEC as well.
The postoperative recurrence, approximately 17 to
35 %, is thought to be a very important predictive progno-
sis indicator for classic chordomas. Additionally, classic
chordoma has the potentiality to metastasize to the lung,
bone, and liver in about 3 to 48 % patients [5, 23, 30–32].
Among them, the chordoma is most likely to metastasize
to the lungs (58 %), then to the lymph nodes (33 %), to the
liver (22 %), to the bone (17 %), and to the skeletal muscle
(9 %) [33]. In contrast, recurrence and metastasis ap-
peared in only one SEC, though a total of four subtotal
resections were performed. The most important reason is
that the sharply circumscribed margins and the absence of
bone involvement made complete resection possible. An-
other reason may be the lessened aggressiveness of SEC.
However, the 19th patient suffered from a serious recur-
rence and metastasis after the subtotal resection of intra-
medullary tumor. Hence, total en bloc resection should
also be suggested to avoid recurrence and metastasis for
SECs, especially for the dumbbell-shaped ones. Alotaibi et
al. [34] also reviewed the patients suffering intradural
chordoma at the skull base with a good result of 5-year
recurrence-free survival (RFS) and overall survival (OS),
particularly the patients who had undergone complete
resection. Without any doubt, the low recurrence and me-
tastasis rates contribute to the better prognosis than the
classic.
In summary, SEC is an extremely rare and special sub-
type of chordoma with the following characteristics: (1)
the absence of bone involvement; (2) the similar morph-
ology with neurogenic tumors; (3) the low aggressive
biologic behavior; (4) a better prognosis than the classic
chordoma. Because of the limited quantities, further
studies are required to better understand SEC’s origin-
ation, immunochemistry, differential diagnosis, biologic
behavior, and prognosis.
Conclusions
Spine extra-osseous chordoma, usually located in the
cervical and epidural region, is extremely rare. SEC is
characterized with the less aggressiveness, the lower rate
of recurrence and metastasis, and the better prognosis
than those of the osseous origin. Though complete exci-
sion can be achieved generally, differential diagnosis of
spine neurogenic tumors and the following en bloc re-
section should be made as carefully as possible.
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